| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.1 | 0.04 |